Structure-based drug design and potent anti-cancer activity of tricyclic 5:7:5-fused diimidazo[4,5-d:4′,5′-f][1,3]diazepines
Keywords: فعالیت ضد سرطان; Organic synthesis and medicinal chemistry; Diimidazo[4,5-d:4′,5′-f][1,3]diazepines; Anti-cancer activity; Lung, breast, prostate and ovarian cancers; In vitro screening; Structure–activity relationship (SAR) studies; DDX3 as potential target